Early detection is key. Bone Densitometry (DEXA) is an advanced technology that safely, accurately and painlessly measures bone density and mineral content of the spine, hip, and wrist in order to determine the risk of developing osteoporosis. Approximately 50% of women over age 50 are at risk of sustaining an osteoporotic fracture.

Considered the most reliable measurement of bone density, DEXA scans are used for both assessment of risk and for follow-up serial measurements. (Source: Mainline Health Newsletter)

With DEXA, doctors are better equipped to detect and treat bone loss in its earliest stages, so as to prevent the disease or lessen its impact. During a comprehensive DEXA evaluation, Bone Mineral Density (BMD) is calculated and compared to normal BMD values, matched for age and gender, to confirm or exclude osteoporosis. A low BMD may predict the likelihood of developing osteoporosis and can help determine a proactive treatment plan.

The Pixi Scan

Another screening tool, the Pixi Scan, measures bone density at only one site, such as the foot. Women who are perimenopausal or postmenopausal should ask their doctors about baseline testing and which test is best based on their medical history. (Source: Mainline Health Newsletter)